LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Back to previous search Search history
Advanced search

Your last searches

  1. AU="Brauer, Heidi R."
  2. AU="Jardim, Bruno"
  3. AU="Roh, Daeyoung"
  4. AU=Wood Thomas K.
  5. AU="Brian Wrotniak"
  6. AU="Mejía, Paúl"
  7. AU="Broeck, C Van Den"
  8. AU="Hei Sook Sul"
  9. AU="Jubil Thomas"
  10. AU="Liu, Mingjun"
  11. AU="Ramírez, Cecilia de la Luna"
  12. AU="Cloquell, Ana"
  13. AU="William P. Cawthorn"
  14. AU="Graham-Brown, M P M"
  15. AU="Smedholen, Madelen Foss"
  16. AU="Waldner, Andreas"
  17. AU="Awni Alshurafa"
  18. AU="Qiqi Xin"
  19. AU="Jamal, Bilal"
  20. AU="Andeol, Guillaume"
  21. AU=Binz Thomas
  22. AU=Yorlets Rachel R.
  23. AU="Klawitter, Sandra"
  24. AU="Wheeler, Jeanna M"
  25. AU="Kavishe, Bazil Baltazar"
  26. AU=Muench Ricardo AU=Muench Ricardo
  27. AU="Guler, Emrah"
  28. AU="Kim, Kyeong Bae"
  29. AU="Birindelli, S"
  30. AU="Monguió-Tortajada, Marta"
  31. AU="Kumta, Nikhil A"
  32. AU="Wu, Wenli"
  33. AU="Curland, Nele"
  34. AU="Redish, A David"
  35. AU="Patterson, Bradley"
  36. AU="Lombardi, Gianmarco"
  37. AU="Rassl, Doris"
  38. AU="Román, Pablo"

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Panic attacks associated with citalopram.

    Brauer, Heidi R / Nowicki, Paul W / Catalano, Glenn / Catalano, Maria C

    Southern medical journal

    2002  Volume 95, Issue 9, Page(s) 1088–1089

    Abstract: Citalopram is the newest selective serotonin reuptake inhibitor (SSRI) available in the United States. It is currently approved by the Food and Drug Administration for the treatment of major depression. However, a number of studies have found it to be ... ...

    Abstract Citalopram is the newest selective serotonin reuptake inhibitor (SSRI) available in the United States. It is currently approved by the Food and Drug Administration for the treatment of major depression. However, a number of studies have found it to be effective in the treatment of panic disorder as well. While there have been no previous case reports of citalopram inducing panic attacks in patients, this phenomenon has been reported with other members of the SSRI class of antidepressants. We present the case of a 61-year-old woman who had frank panic attacks after her citalopram dose was increased. She had had no history of anxiety symptoms. Anxiety abated completely upon discontinuance of citalopram therapy.
    MeSH term(s) Citalopram/adverse effects ; Female ; Humans ; Middle Aged ; Panic Disorder/chemically induced ; Serotonin Uptake Inhibitors/adverse effects
    Chemical Substances Serotonin Uptake Inhibitors ; Citalopram (0DHU5B8D6V)
    Language English
    Publishing date 2002-09
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 185329-6
    ISSN 1541-8243 ; 0038-4348
    ISSN (online) 1541-8243
    ISSN 0038-4348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.117: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 336: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Topiramate Overdose: A Case Report and Literature Review.

    Smith, Amanda G. / Brauer, Heidi R. / Catalano, Glenn / Catalano, Maria C.

    Epilepsy & behavior : E&B

    2001  Volume 2, Issue 6, Page(s) 603–607

    Abstract: Topiramate is a medication introduced in the United States in 1997 for the treatment of epilepsy. Studies are currently underway to determine its effectiveness in the treatment of multiple conditions including bipolar disorder. It is generally well ... ...

    Abstract Topiramate is a medication introduced in the United States in 1997 for the treatment of epilepsy. Studies are currently underway to determine its effectiveness in the treatment of multiple conditions including bipolar disorder. It is generally well tolerated at doses commonly used in the clinical setting, however, there is little information regarding its safety in overdose. We report the case of a 24-year-old woman who ingested 4000 mg of topiramate in a suicide attempt. She was asymptomatic following the overdose and did not develop any adverse sequelae. In this article we will discuss the commonly seen side effects of topiramate use and examine the available data concerning topiramate overdose. We will review recommendations for the management of such an overdose.
    Language English
    Publishing date 2001-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2010587-3
    ISSN 1525-5069 ; 1525-5050
    ISSN (online) 1525-5069
    ISSN 1525-5050
    DOI 10.1006/ebeh.2001.0299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5289: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top